ZBTB8OS | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	14 studies	20% ± 6%	Explore
plasma cell	11 studies	32% ± 12%	Explore
B cell	11 studies	21% ± 4%	Explore
endothelial cell	10 studies	27% ± 6%	Explore
macrophage	9 studies	22% ± 9%	Explore
astrocyte	9 studies	29% ± 12%	Explore
CD16-positive, CD56-dim natural killer cell, human	8 studies	21% ± 2%	Explore
glutamatergic neuron	8 studies	45% ± 25%	Explore
epithelial cell	8 studies	36% ± 16%	Explore
oligodendrocyte	8 studies	27% ± 8%	Explore
plasmablast	7 studies	35% ± 24%	Explore
non-classical monocyte	7 studies	27% ± 11%	Explore
regulatory T cell	7 studies	18% ± 2%	Explore
CD8-positive, alpha-beta T cell	6 studies	22% ± 5%	Explore
classical monocyte	6 studies	24% ± 8%	Explore
fibroblast	6 studies	24% ± 6%	Explore
GABAergic neuron	6 studies	48% ± 22%	Explore
plasmacytoid dendritic cell	6 studies	23% ± 7%	Explore
memory B cell	6 studies	17% ± 2%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	18% ± 2%	Explore
CD16-negative, CD56-bright natural killer cell, human	5 studies	20% ± 4%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	21% ± 3%	Explore
retinal cone cell	5 studies	37% ± 21%	Explore
alveolar macrophage	5 studies	22% ± 3%	Explore
ciliated cell	5 studies	30% ± 10%	Explore
oligodendrocyte precursor cell	5 studies	27% ± 9%	Explore
gamma-delta T cell	5 studies	21% ± 7%	Explore
adipocyte	5 studies	21% ± 3%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	16% ± 0%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	18% ± 3%	Explore
mature NK T cell	4 studies	19% ± 2%	Explore
neuron	4 studies	30% ± 13%	Explore
microglial cell	4 studies	20% ± 5%	Explore
basal cell	4 studies	32% ± 11%	Explore
retinal rod cell	4 studies	21% ± 6%	Explore
lymphocyte	4 studies	22% ± 5%	Explore
abnormal cell	4 studies	21% ± 3%	Explore
goblet cell	4 studies	20% ± 3%	Explore
interneuron	4 studies	48% ± 23%	Explore
conventional dendritic cell	3 studies	30% ± 9%	Explore
exhausted T cell	3 studies	22% ± 8%	Explore
GABAergic interneuron	3 studies	21% ± 5%	Explore
myeloid cell	3 studies	28% ± 9%	Explore
club cell	3 studies	19% ± 1%	Explore
erythroblast	3 studies	25% ± 12%	Explore
germinal center B cell	3 studies	19% ± 2%	Explore
endothelial cell of lymphatic vessel	3 studies	21% ± 6%	Explore
dendritic cell	3 studies	31% ± 9%	Explore
enteroendocrine cell	3 studies	24% ± 6%	Explore
CD8-positive, alpha-beta memory T cell	3 studies	23% ± 7%	Explore
transit amplifying cell	3 studies	27% ± 12%	Explore
hepatocyte	3 studies	38% ± 13%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	3 studies	18% ± 4%	Explore
double negative thymocyte	3 studies	21% ± 6%	Explore
mucosal invariant T cell	3 studies	17% ± 1%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
brain	11 studies	34% ± 19%	Explore
peripheral blood	8 studies	21% ± 6%	Explore
lung	6 studies	25% ± 11%	Explore
intestine	4 studies	19% ± 3%	Explore
liver	4 studies	25% ± 10%	Explore
eye	3 studies	30% ± 2%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
bladder	100%	1035.62	21 / 21	100%	18.82	504 / 504
breast	100%	854.95	459 / 459	100%	18.07	1118 / 1118
esophagus	100%	981.32	1445 / 1445	100%	19.35	183 / 183
intestine	100%	1045.98	966 / 966	100%	17.03	527 / 527
liver	100%	638.88	226 / 226	100%	13.69	406 / 406
pancreas	100%	586.63	328 / 328	100%	16.94	178 / 178
prostate	100%	1036.60	245 / 245	100%	17.23	502 / 502
stomach	100%	882.25	359 / 359	100%	17.27	286 / 286
thymus	100%	951.92	653 / 653	100%	19.07	605 / 605
uterus	100%	804.10	170 / 170	100%	22.25	459 / 459
brain	100%	858.74	2639 / 2642	100%	14.89	705 / 705
lung	100%	924.39	577 / 578	100%	19.46	1155 / 1155
skin	100%	791.32	1808 / 1809	100%	16.14	471 / 472
kidney	100%	950.51	89 / 89	100%	13.27	898 / 901
ovary	99%	613.81	179 / 180	100%	18.35	430 / 430
adrenal gland	100%	927.47	258 / 258	99%	10.82	228 / 230
adipose	100%	805.60	1204 / 1204	0%	0	0 / 0
blood vessel	100%	961.21	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	39.35	29 / 29
muscle	100%	896.24	803 / 803	0%	0	0 / 0
spleen	100%	1124.04	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	18.40	45 / 45
ureter	0%	0	0 / 0	100%	23.43	1 / 1
heart	99%	690.79	854 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	91%	7.83	73 / 80
peripheral blood	75%	749.48	701 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006388	Biological process	tRNA splicing, via endonucleolytic cleavage and ligation
GO_0005654	Cellular component	nucleoplasm
GO_0072669	Cellular component	tRNA-splicing ligase complex
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding
GO_0046872	Molecular function	metal ion binding

IV. Literature review

[source]

Gene name	ZBTB8OS
Protein name	Zinc finger and BTB domain containing 8 opposite strand Protein archease (Protein ZBTB8OS) (Zinc finger and BTB domain-containing opposite strand protein 8) Protein archease
Synonyms	ARCH hCG_2032080
Description	FUNCTION: Component of the tRNA-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit RTCB. Together with DDX1, acts by facilitating the guanylylation of RTCB, a key intermediate step in tRNA ligation. .
Accessions	ENST00000341885.6 ENST00000468695.6 [Q8IWT0-1] ENST00000373501.6 S4R426 A0A8C8MQ05 ENST00000479075.6 A8K0B5 F6SII6 Q8IWT0 ENST00000492007.6 A0A087WUU3 A0A087WTK6 A0A087X0V4 ENST00000436661 H7C3R6 ENST00000373506.8 A0A087WW18 ENST00000465588.2 D3DPQ2 ENST00000476493.6 ENST00000498691.5 ENST00000468695 A0A087X1H4 ENST00000436661.6 [Q8IWT0-2] ENST00000473294.7

ZBTB8OS report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review